MX2015003564A - Composiciones y metodos de uso de un compuesto de control de inapetencia. - Google Patents

Composiciones y metodos de uso de un compuesto de control de inapetencia.

Info

Publication number
MX2015003564A
MX2015003564A MX2015003564A MX2015003564A MX2015003564A MX 2015003564 A MX2015003564 A MX 2015003564A MX 2015003564 A MX2015003564 A MX 2015003564A MX 2015003564 A MX2015003564 A MX 2015003564A MX 2015003564 A MX2015003564 A MX 2015003564A
Authority
MX
Mexico
Prior art keywords
inapetence
compositions
methods
livestock
control composite
Prior art date
Application number
MX2015003564A
Other languages
English (en)
Spanish (es)
Inventor
Bill Zollers
Linda Rhodes
Ernst Heinen
Gopinath Devaraj
Original Assignee
Aratana Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aratana Therapeutics Inc filed Critical Aratana Therapeutics Inc
Publication of MX2015003564A publication Critical patent/MX2015003564A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Dermatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2015003564A 2012-09-27 2013-09-27 Composiciones y metodos de uso de un compuesto de control de inapetencia. MX2015003564A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261706164P 2012-09-27 2012-09-27
PCT/US2013/062227 WO2014052780A2 (en) 2012-09-27 2013-09-27 Compositions and methods of use of an inappetance-controlling compound

Publications (1)

Publication Number Publication Date
MX2015003564A true MX2015003564A (es) 2015-11-16

Family

ID=50339468

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015003564A MX2015003564A (es) 2012-09-27 2013-09-27 Composiciones y metodos de uso de un compuesto de control de inapetencia.
MX2022015141A MX2022015141A (es) 2012-09-27 2015-03-19 Composiciones y metodos de uso de un compuesto de control de inapetencia.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022015141A MX2022015141A (es) 2012-09-27 2015-03-19 Composiciones y metodos de uso de un compuesto de control de inapetencia.

Country Status (18)

Country Link
US (1) US11090292B2 (2)
EP (3) EP3524260B1 (2)
JP (2) JP6779618B2 (2)
KR (6) KR20250048114A (2)
CN (2) CN105072909A (2)
AR (2) AR092713A1 (2)
AU (2) AU2013323349B2 (2)
BR (1) BR112015006282B1 (2)
CA (1) CA2886091C (2)
DK (1) DK3524260T3 (2)
ES (1) ES2959427T3 (2)
MX (2) MX2015003564A (2)
NZ (2) NZ707174A (2)
PL (1) PL3524260T3 (2)
PT (1) PT3524260T (2)
RU (1) RU2648958C2 (2)
TW (3) TWI732158B (2)
WO (1) WO2014052780A2 (2)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2011105611A1 (ja) 2010-02-26 2013-06-20 ラクオリア創薬株式会社 悪液質を治療するためのグレリン受容体作動物質
US10039813B2 (en) 2012-02-07 2018-08-07 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
TWI732158B (zh) 2012-09-27 2021-07-01 美商雅瑞塔那醫療公司 使用食慾喪失控制化合物之組合物及方法
WO2014144231A1 (en) 2013-03-15 2014-09-18 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
ES2902795T3 (es) * 2015-01-28 2022-03-29 Elanco Animal Health Incorporated Composición para uso crónico como compuesto para aumentar de peso
WO2016138099A1 (en) 2015-02-24 2016-09-01 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
CN110022688A (zh) * 2016-11-11 2019-07-16 希尔氏宠物营养品公司 宠物食物的组合物和方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US193273A (en) * 1877-07-17 Improvement in material for pulley-covers
JP2893901B2 (ja) * 1990-09-07 1999-05-24 株式会社岐阜免疫研究所 動物用抗体含有油性ペースト製剤
CA2095786A1 (en) 1992-05-08 1993-11-09 Franco J. Vaccarino Method of stimulating appetite
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
ATE446758T1 (de) 2000-05-31 2009-11-15 Pfizer Prod Inc Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
EP1181933A3 (en) * 2000-06-29 2002-04-10 Pfizer Products Inc. Use of growth hormone secretagogues for stimulating or increasing appetite
US8309603B2 (en) * 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US7476653B2 (en) * 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
US7491695B2 (en) * 2003-06-18 2009-02-17 Tranzyme Pharma Inc. Methods of using macrocyclic modulators of the ghrelin receptor
JP2007532495A (ja) * 2004-04-07 2007-11-15 ガストロテック・ファルマ・アクティーゼルスカブ グレリン欠乏を治療するための分泌促進薬の使用
EP1812045A2 (en) * 2004-10-27 2007-08-01 Gastrotech Pharma A/S Uses of secretagogues for treatment of organ transplant patients
AU2006310690B2 (en) * 2005-11-02 2012-05-31 Société des Produits Nestlé S.A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
BRPI0708895A2 (pt) * 2006-03-13 2011-06-28 Liat Mintz uso de variante de junção de grelina para tratar caquexia e/ou anorexia e/ou anorexia-caquexia e/ou subnutrição e/ou lipodistrofia e/ou atrofia muscular e/ou estimulação do apetite
AU2007300526B2 (en) * 2006-09-27 2011-07-21 Ipsen Pharma S.A.S. Analogs of ghrelin substituted at the N-terminal
JP2008127377A (ja) * 2006-11-24 2008-06-05 Jichi Medical Univ Ｇｈｓ−ｒ作動薬を含有してなるメタボリックシンドローム又は高血圧症の予防・治療剤。
US20080226802A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Beverage having natural sweeteners with one or more stevia components and source of berry
TWI429436B (zh) * 2007-04-10 2014-03-11 Helsinn Therapeutics Us Inc 使用生長激素促泌素治療或預防嘔吐之方法
RU2007129408A (ru) * 2007-07-31 2009-02-10 Игорь Николаевич Жирков (RU) Способ выращивания поросят в период откорма
FR2920295B1 (fr) 2007-09-05 2009-12-11 Desvac Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable
KR101531202B1 (ko) * 2007-11-12 2015-06-24 산에이겐 에후.에후. 아이. 가부시키가이샤 스테비아 추출물의 감미질 개선
SG174476A1 (en) * 2009-03-26 2011-10-28 Takeda Pharmaceutical Pyrazole compound
JPWO2011105611A1 (ja) * 2010-02-26 2013-06-20 ラクオリア創薬株式会社 悪液質を治療するためのグレリン受容体作動物質
TWI732158B (zh) 2012-09-27 2021-07-01 美商雅瑞塔那醫療公司 使用食慾喪失控制化合物之組合物及方法

Also Published As

Publication number Publication date
JP2016500660A (ja) 2016-01-14
NZ707174A (en) 2018-10-26
TW201417812A (zh) 2014-05-16
NZ746394A (en) 2019-01-25
TW202106298A (zh) 2021-02-16
RU2648958C2 (ru) 2018-03-28
WO2014052780A2 (en) 2014-04-03
CA2886091C (en) 2021-11-30
AR092713A1 (es) 2015-04-29
KR20230097201A (ko) 2023-06-30
KR20190143484A (ko) 2019-12-30
US20140088139A1 (en) 2014-03-27
RU2015114996A (ru) 2016-11-20
KR20150058345A (ko) 2015-05-28
AU2013323349A1 (en) 2015-05-07
AU2013323349B2 (en) 2016-09-15
EP4302825A2 (en) 2024-01-10
EP4302825A3 (en) 2024-07-03
AR123902A2 (es) 2023-01-25
JP6796097B2 (ja) 2020-12-02
DK3524260T3 (da) 2023-10-09
EP3524260A1 (en) 2019-08-14
BR112015006282A2 (pt) 2017-07-04
KR20250048114A (ko) 2025-04-07
TWI667024B (zh) 2019-08-01
WO2014052780A3 (en) 2014-06-26
PL3524260T3 (pl) 2023-11-27
TW201924680A (zh) 2019-07-01
PT3524260T (pt) 2023-10-13
US11090292B2 (en) 2021-08-17
EP2906041A4 (en) 2016-10-26
BR112015006282B1 (pt) 2021-11-23
AU2016216741A1 (en) 2016-09-15
KR20220003640A (ko) 2022-01-10
CN111419845A (zh) 2020-07-17
CN105072909A (zh) 2015-11-18
JP6779618B2 (ja) 2020-11-04
JP2018117625A (ja) 2018-08-02
ES2959427T3 (es) 2024-02-26
KR20210009438A (ko) 2021-01-26
EP3524260B1 (en) 2023-09-13
EP2906041A2 (en) 2015-08-19
CA2886091A1 (en) 2014-04-03
AU2016216741B2 (en) 2018-02-15
MX2022015141A (es) 2023-02-01
TWI732158B (zh) 2021-07-01

Similar Documents

Publication Publication Date Title
MX373330B (es) Composiciones y métodos que comprenden bupropion o compuestos relacionados y dextrometorfano.
PH12017500070A1 (en) Methods of treating cancer using tigit inhibitors and anti-cancer agents
MX2015003564A (es) Composiciones y metodos de uso de un compuesto de control de inapetencia.
CL2015003801A1 (es) Formulaciones de anticuerpos y metodos
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
GB2535876A (en) Absorbent clumping animal litter compositions
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201590880A1 (ru) Композиции и способы лечения протеинопатий
UA117451C2 (uk) Терапевтично активні сполуки і способи їх застосування
PE20151727A1 (es) Acido 2-aza-biciclo[2.2.1]heptano-3-carboxilico (bencil-ciano-metil)-amidas sustituidas inhibidores de catepsina c
WO2014145159A3 (en) Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use
EA201790273A1 (ru) Флагеллиновые композиции и их применение
NZ708453A (en) Germicidal compositions comprising carboxylic acid mixture and use as topical disinfectants
MX2019006893A (es) Inhibidores heterociclicos de mct4.
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
BR112017026535A2 (pt) composto de fórmula estrutural i, enantiômero isolado, composição farmacêutica, método para inibir atividade do transportador de monocarboxilato mct4, método para inibir seletivamente atividade do transportador de monocarboxilato mct4, método para tratar um distúrbio mediado por transportador de monocarboxilato mct4 e uso de um composto
MX364800B (es) Tilmicosina de accion prolongada mejorada y el uso de la misma en el tratamiento del complejo respiratorio bovino (crb) y en el periodo de la vaca seca.
EA201690323A1 (ru) Способы лечения заболеваний уха у детей
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
MX372642B (es) Un metodo para controlar plagas que habitan en la superficie del agua.
AR097143A1 (es) Composición alimenticia mineral para lamer para rumiantes y método para prepararla
EA201591507A1 (ru) Лечение рассеянного склероза лахинимодом
MX2016007356A (es) Composicion para administracion oral de agentes bioactivos.
MX2020001428A (es) Composiciones de grapiprant y metodos para usar las mismas.
MX383741B (es) Composiciones y métodos para el uso crónico de un compuesto para aumentar el peso.

Legal Events

Date Code Title Description
FG Grant or registration